Exanthems probably mediated by superantigen. About two cases;Exantemas probablemente mediados por superantígenos. A propósito de dos observaciones

Actas Dermo-Sifiliograficas

Volumn 90, Issue 1-2, 1999, Pages 31-36

  Enguídanos, Eduardo Nagore ^a   Motilla, José maría Sánchez ^a   Bosch, María Isabel Febrer ^a   Marí, José Carlos Alba ^a   González, Eva Huerta ^a   Boniche, Adolfo Aliaga ^a  

^a NONE

Author keywords

Exanthems; Superantigens

Indexed keywords

EID: 0041761762     PISSN: 00017310     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Roitt IM, Brostoff J, Male DK. Inmunología. Barcelona. Masson, S.A. 1994.
2. Manders SM, Heymann WR, Atillasoy E, Kleeman J, Schlievert PM. Recurrent toxinmediated perineal erythema. Arch Dermatol 1996;132:57-60.
3. Todd JK, Franco-Buff A, Lawellin DW, Vasil ML. Phenotypic distinctiveness of Staphylococcus aureus strains associated with toxic shock syndrome. Infect Immun 1984;45:339-44.
4. White J, Herman A, Pullen AM, Kubo RT, Kappler JW, Marrack P. The V beta-specific superantigen staphylococcal enterotoxin B: stimulation of mature T cells and clonal deletion in neonatal mice. Cell 1989;56:27-35.
5. Braun MA, Gerlach D, Hartwig VF y cols. Stimulation of human T cells by streptococcal «superantigens» erythrogenic toxins (scarlet fever toxins). J Immunol 1993;150: 2457-66.
6. Abe J, Onimam M, Matsumoto S y cols. Clinical role for a superantigen in Yersinia pseudotuberculosis infection. J Clin Invest 1997;99:1823-30.
7. Musser JM, Hauser AR, Kim M, Schlievert PM, Nelson K, Selander RK. Streptococcus pyogenes causing toxic shock-like syndrome and other invasive diseases: clonal diversity and pyogenic exotoxin expression. Proc Natl Acad Sci USA 1991;88:2668-72.
8. Leung DYM, Meissner HC, Fulton DR, Murray DL, Kotzin BC, Schlievert PM. Toxic shock syndrome toxin-secreting Staphylococcus aureus in Kawasaki syndrome. Lancet 1993;342:1385-8.
9. Schlievert PM, Blomster DA. Production of Staphylococcal pyrogenic exotoxin type C: influence of physical and chemical factors. J Infect Dis 1983;147:236-42.
10. Hermans A, Croteau G, Sekaly RP, Kappler J, Marrack P. HLA-DR alleles differ in their ability to present staphylococcal enterotoxins to T-cell. J Exp Med 1990;172:709-7.
11. Schlievert PM. Role of superantigens in human disease. J Infect Dis 1993;167:997-1002.
12. Mollich JA, Cook RG, Rich RR. Class II molecules are specific receptors for Staphylococcus enterotoxin A. Science 1989;244:817-820.
13. Blanck C, Luz A, Bendigs S, Erdmann A, Wagner H, Heeg K. Superantigens and endotoxin synergize in the induction of lethal shock. Eur J Immunol 1997;27:825-33.
14. Rago JV, Schlievert PM. Mechanisms of pathogenesis of staphylococcal and streptococcal superantigens. Curr Top Microbiol Immunol 1998;225:81-97.
15. Van Lierde S, van Leeuwen WJ, Ceuppens J, Cornette L, Gouban P, van Eldere J, Toxic shock syndrome without rash in a young child: link with syndrome of hemorrhagic shock and encephalopathy? J Pediatr 1997;131:130-4.
16. McFadden JP, Noble WC, Camp RDR. Superantigenic exotoxin-secreting potential of stahpylococci isolated from atopic eczematous skin. Br J Dermatol 1993;128:631-2.
17. Jackow CM, Gather JC, Hearne V, Asano AT, Musser JM, Duvic M. Association of erythrodermic cutaneous T-cell lymphoma, superantigen-positive Staphylococcus aurens, and oligoclonal T-cell receptor Vb gene expansion. Blood 1997;89:32-40.
18. Takei S, Arora YK, Walker SM. Intravenous immunoglobulin contains specific antibodies in hibitory to activation of T cells by staphylococcal toxin superantigens. J Clin Invest 1993;91:602-7.
19. Mori M, Tomono N, Yokota S. Coronary arteritis of Kawasaki disease unresponsive to highdose intravenous gammaglobulin succesfully treated with plasmapheresis. Nikkon Rinsho Meneki Gakkai Kaishi 1998;18:282-8 (Resumen).
20. Givner LB, Gray L, O'Shèa TM. Antibodies to tumor necrosis factor-alpha: use as adjuntive therapy in established group B streptococcal disease in newbom rats. Pediatr Res 1995;38:551-4.